July 22, 2022
Komeito Meeting on July 21 Lawmakers of Komeito on July 21 questioned the way Shionogi’s oral COVID-19 antiviral has been reviewed on the newly created emergency approval pathway, calling for evaluating the drug’s benefits in tackling currently prevalent coronavirus variants...read more